Look for:

Our offer for

EVOTEC AG


ISIN:
DE0005664809
WKN:
566480

2024/06/25 10:56:30
Price
8.665 EUR
Difference 4.59% (0.38)

General attributes

ISINDE0005664809
SymbolEVT
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1,565 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)8.785 EUR (250)
Ask (Ask size)8.865 EUR (250)
Open8.77 EUR
High8.88 EUR
Low8.665 EUR
Close (prev. day)8.285 EUR
VWAP8.86766 EUR
Volume (pcs)1,131
Trading volume10,029.32
Number of trades5
Last size30

Futures and Options

Related Futures24
Related Options-

PDF Downloads

Company report: EVOTEC AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/06/25 10:56:30
Price
8.665 EUR
Difference 4.59% (0.38)

General attributes

ISINDE0005664809
SymbolEVT
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1,565 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)8.785 EUR (250)
Ask (Ask size)8.865 EUR (250)
Open8.77 EUR
High8.88 EUR
Low8.665 EUR
Close (prev. day)8.285 EUR
VWAP8.86766 EUR
Volume (pcs)1,131
Trading volume10,029.32
Number of trades5
Last size30

Performance and Risk

6m1Y3Y
Perf (%)-60.42%-60.72%-77.45%
Perf (abs.)-12.65-12.81-28.46
Beta1.851.911.09
Volatility74.2161.0653.46
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)7.975 EUR (992)
Ø price 30 days | Ø volume 30 days (pcs.)8.911 EUR (801)
Ø price 100 days | Ø volume 100 days (pcs.)11.716 EUR (708)
Ø price 250 days | Ø volume 250 days (pcs.)16.308 EUR (431)
YTD High | date21.360 EUR (2024/01/02)
YTD Low | date7.320 EUR (2024/06/19)
52 Weeks High | date24.300 EUR (2023/08/01)
52 Weeks Low | date7.320 EUR (2024/06/19)

All listings for EVOTEC AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/06/2520:348.775 EUR0.0015
Duesseldorf2024/06/2519:318.765 EUR0.005
Euronext Milan MTF Global Equity Market2024/06/2517:448.84 EUR0.001
Euronext Milan MTF Trading After Hours2024/06/1918:057.055 EUR0.002
FINRA other OTC Issues2024/06/1419:048.98 USD0.001
Frankfurt2024/06/2521:498.75 EUR0.0713
Hamburg2024/06/2508:208.785 EUR0.001
Hanover2024/06/2514:168.645 EUR0.002
London Stock Exchange European Trade Reporting2024/06/2517:308.805 EUR0.001
Munich2024/06/2510:568.665 EUR0.015
SIX Swiss Exchange2023/04/1217:3527.76 CHF0.001
Stuttgart2024/06/2521:458.775 EUR0.26109
Tradegate2024/06/2521:488.755 EUR3.45740
Vienna Stock Exchange2024/06/2517:328.85 EUR0.003
Xetra2024/06/2517:438.825 EUR7.992,462

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1286&ID_TYPE_IMAGE_LOGO=2

Contact Details

EVOTEC SE
- -
Manfred Eigen Campus, Essener Bogen 7 - 22419 Hamburg
Telefon: +49-40-56081-0
Fax: +49-40-56081-222
E-mail: info@evotec.com

PDF Downloads

Company report: EVOTEC AGPDF Download

Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.

Members of Management Board

Mario PolywkaChairman of Managing Board
Cord DohrmannMember of Executive Committee
Craig JohnstoneMember of Executive Committee
Matthias EversMember of Executive Committee
Aurelie DalbiezMember of Executive Committee
Laetitia RouxelMember of Executive Committee

Board of directors

Iris Löw-FriedrichChairman of Supervisory Board
Constanze Ulmer-EilfortMember of Supervisory Board
Duncan McHaleMember of Supervisory Board
Camilla LanguilleMember of Supervisory Board
Roland SackersMember of Supervisory Board
Wesley WheelerMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer